BioGX Launches Six CE-Mark Tests for Meningitis and Antibiotic Resistance

AMSTERDAM, May 24, 2018 -- (Healthcare Sales & Marketing Network) -- BioGX B.V. continues its *BD MAX™ menu expansion with the launch of six additional CE-Mark infectious disease tests on Becton, Dickinson and Company's BD MAX™ Sample-to-Answer platform.... Diagnostics, Product Launch BioGX, BD , meningitis, vancomycin resistance
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news